Emily M. Walker, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · University of California San Francisco
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Emily M. Walker’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,642
Medicare paid this office $8,642 for 147 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 83 | $4,194 | $48 |
| Return visit (30+ min) | 42 | $2,163 | $51 |
Who their Medicare patients are
147 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 12% · Women 65% · Also on Medicaid 25% · Health risk score 1.02. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 52% · Chronic kidney disease 18% · Depression 18% · Cancer 17% · Diabetes 14% · Coronary heart disease 14% · Atrial fibrillation 10% · Heart failure 9%.
The office billed $70,659, Medicare allowed $12,017 and paid $8,642; for 169 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 147 | 169 | 73 | 1.02 | $70,659 | $8,642 |
| 2023 | 327 | 389 | 74 | 1.54 | $209,424 | $26,950 |
| 2022 | 254 | 292 | 72 | 1.39 | $138,006 | $16,499 |
| 2021 | 204 | 240 | 70 | 1.28 | $104,113 | $14,153 |
| 2020 | 169 | 189 | 72 | 1.45 | $80,980 | $7,715 |
| 2019 | 151 | 176 | 68 | 1.67 | $50,028 | $9,016 |
| 2018 | 79 | 101 | 63 | 1.70 | $11,613 | $4,995 |
| 2017 | 139 | 322 | 69 | 1.16 | $80,848 | $14,209 |
| 2016 | 144 | 254 | 69 | 1.15 | $66,484 | $10,263 |
| 2015 | 169 | 310 | 71 | 1.08 | $67,539 | $13,351 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 218 | $17,223 | $69 |
| Long return visit (40+ min) | 33 | $3,539 | $104 |
| Short return visit (20+ min) | 59 | $2,808 | $45 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $1,571 | $63 |
2022: 4 services
| Return visit (30+ min) | 97 | $6,728 | $63 |
| Short return visit (20+ min) | 127 | $5,567 | $42 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,815 | $165 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $672 | $35 |
2021: 4 services
| Return visit (30+ min) | 79 | $5,519 | $66 |
| Short return visit (20+ min) | 86 | $4,401 | $47 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,088 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,064 | $48 |
2020: 4 services
| Return visit (30+ min) | 64 | $3,034 | $45 |
| Short return visit (20+ min) | 74 | $2,681 | $35 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $805 | $62 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $683 | $36 |
2019: 2 services
| Return visit (30+ min) | 114 | $7,011 | $56 |
| Short return visit (20+ min) | 41 | $1,562 | $36 |
2018: 2 services
| Return visit (30+ min) | 56 | $3,671 | $56 |
| Short return visit (20+ min) | 27 | $891 | $30 |
2017: 5 services
| Short return visit (20+ min) | 104 | $6,321 | $40 |
| Return visit (30+ min) | 58 | $5,311 | $69 |
| Influenza vaccine split virus, preservative free | 15 | $708 | $47 |
| Administration of influenza virus vaccine | 17 | $456 | $27 |
| Urinalysis, manual test | 15 | $55 | $3 |
2016: 3 services
| Short return visit (20+ min) | 94 | $4,579 | $38 |
| Return visit (30+ min) | 64 | $3,240 | $48 |
| Urinalysis, manual test | 12 | $44 | $3 |
2015: 5 services
| Short return visit (20+ min) | 147 | $9,393 | $48 |
| Return visit (30+ min) | 21 | $1,660 | $75 |
| Administration of influenza virus vaccine | 14 | $372 | $27 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $231 | $18 |
| Urinalysis, manual test | 27 | $92 | $3 |
Drugs they prescribed that Part D paid
$24,678
Pharmacies billed $24,678 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
340 generic and fewer than 11 brand-name prescriptions · $24,678 in drug cost · 56 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Paxlovid | 31 | $2,859 | $92 |
| Atorvastatin | 36 | $477 | $13 |
| Fluticasone Propionate | 16 | $257 | $16 |
| Albuterol Sulfate Hfa | 14 | $229 | $16 |
| Rosuvastatin | 14 | $182 | $13 |
See all 8 drugs
| Paxlovid | 31 | $2,859 | $92 |
| Atorvastatin | 36 | $477 | $13 |
| Fluticasone Propionate | 16 | $257 | $16 |
| Albuterol Sulfate Hfa | 14 | $229 | $16 |
| Rosuvastatin | 14 | $182 | $13 |
| Nitrofurantoin Mono-Macro | 23 | $175 | $8 |
| Pantoprazole | 14 | $69 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $64 | $6 |
Year by year
| 2024 | 425 | 218 | None | None | $24,678 |
| 2023 | 985 | 410 | 7% (71) | 11% | $142,155 |
| 2022 | 945 | 410 | 7% (61) | 10% | $84,261 |
| 2021 | 822 | 337 | 5% (37) | None | $75,762 |
| 2020 | 870 | 392 | 5% (41) | None | $83,104 |
| 2019 | 607 | 199 | None | None | $136,638 |
| 2018 | 696 | 218 | 2% (11) | None | $122,535 |
| 2017 | 1,372 | 286 | 8% (106) | None | $39,058 |
| 2016 | 1,533 | 304 | 4% (57) | None | $47,701 |
| 2015 | 654 | 257 | 3% (22) | None | $21,060 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Eliquis | 15 | $19,760 | $1,317 |
| Atorvastatin | 82 | $1,633 | $20 |
| Hydrocodone-Acetaminophen | 35 | $1,491 | $43 |
| Gabapentin | 29 | $936 | $32 |
| Rosuvastatin | 18 | $933 | $52 |
| Levothyroxine | 36 | $725 | $20 |
| Fluticasone Propionate | 26 | $666 | $26 |
| Amlodipine Besylate | 41 | $554 | $14 |
| Benazepril | 18 | $479 | $27 |
| Losartan | 29 | $411 | $14 |
| Diclofenac | 14 | $401 | $29 |
| Albuterol Sulfate Hfa | 14 | $374 | $27 |
| Paxlovid (Eua) | 33 | $349 | $11 |
| Oxycodone | 19 | $344 | $18 |
| Pantoprazole | 14 | $333 | $24 |
| Lisinopril | 20 | $309 | $15 |
| Metformin | 15 | $261 | $17 |
| Tamsulosin | 11 | $246 | $22 |
| Hydrochlorothiazide | 12 | $68 | $6 |
2022: 28 drugs
| Albuterol Sulfate Hfa | 12 | $1,319 | $110 |
| Gabapentin | 32 | $1,108 | $35 |
| Lidocaine | 13 | $1,086 | $84 |
| Diclofenac | 16 | $1,077 | $67 |
| Hydrocodone-Acetaminophen | 25 | $973 | $39 |
| Atorvastatin | 68 | $764 | $11 |
| Rosuvastatin | 18 | $675 | $38 |
| Oxycodone | 23 | $637 | $28 |
| Metoprolol | 22 | $492 | $22 |
| Losartan | 21 | $454 | $22 |
| Levothyroxine | 23 | $453 | $20 |
| Fluticasone Propionate | 23 | $407 | $18 |
| Amlodipine Besylate | 36 | $347 | $10 |
| Omeprazole | 15 | $336 | $22 |
| Tamsulosin | 11 | $308 | $28 |
| Ezetimibe | 12 | $308 | $26 |
| Benazepril | 17 | $291 | $17 |
| Trazodone | 19 | $254 | $13 |
| Famotidine | 13 | $242 | $19 |
| Simvastatin | 15 | $175 | $12 |
| Metformin | 17 | $161 | $9 |
| Triamcinolone Acetonide | 18 | $146 | $8 |
| Lisinopril | 15 | $133 | $9 |
| Paxlovid (Eua) | 12 | $124 | $10 |
| Cephalexin | 16 | $115 | $7 |
| Meloxicam | 11 | $96 | $9 |
| Escitalopram | 11 | $72 | $7 |
| Hydrochlorothiazide | 11 | $63 | $6 |
2021: 23 drugs
| Xarelto | 13 | $9,845 | $757 |
| Albuterol Sulfate Hfa | 18 | $1,221 | $68 |
| Atorvastatin | 56 | $877 | $16 |
| Omeprazole | 30 | $837 | $28 |
| Gabapentin | 20 | $732 | $37 |
| Levothyroxine | 31 | $725 | $23 |
| Rosuvastatin | 11 | $643 | $58 |
| Hydrocodone-Acetaminophen | 18 | $549 | $30 |
| Fluticasone Propionate | 19 | $522 | $27 |
| Metoprolol | 15 | $397 | $26 |
| Ondansetron | 12 | $367 | $31 |
| Amlodipine Besylate | 27 | $303 | $11 |
| Tamsulosin | 18 | $250 | $14 |
| Trazodone | 17 | $216 | $13 |
| Losartan | 11 | $199 | $18 |
| Simvastatin | 17 | $195 | $11 |
| Allopurinol | 12 | $194 | $16 |
| Lorazepam | 14 | $162 | $12 |
| Hydrochlorothiazide | 17 | $122 | $7 |
| Lisinopril | 25 | $120 | $5 |
| Donepezil | 11 | $91 | $8 |
| Montelukast | 13 | $91 | $7 |
| Metformin | 15 | $76 | $5 |
2020: 19 drugs
| Atorvastatin | 77 | $1,521 | $20 |
| Levothyroxine | 36 | $910 | $25 |
| Albuterol Sulfate Hfa | 16 | $828 | $52 |
| Rosuvastatin | 13 | $775 | $60 |
| Metoprolol | 15 | $696 | $46 |
| Fluticasone Propionate | 29 | $555 | $19 |
| Omeprazole | 38 | $548 | $14 |
| Losartan | 26 | $423 | $16 |
| Gabapentin | 18 | $414 | $23 |
| Tamsulosin | 14 | $380 | $27 |
| Amlodipine Besylate | 46 | $338 | $7 |
| Famotidine | 12 | $335 | $28 |
| Hydrocodone-Acetaminophen | 14 | $274 | $20 |
| Metformin | 24 | $258 | $11 |
| Triamcinolone Acetonide | 12 | $195 | $16 |
| Pantoprazole | 12 | $186 | $15 |
| Allopurinol | 15 | $165 | $11 |
| Simvastatin | 12 | $112 | $9 |
| Hydrochlorothiazide | 15 | $109 | $7 |
2019: 14 drugs
| Linzess | 57 | $24,701 | $433 |
| Xifaxan | 11 | $18,696 | $1,700 |
| Motegrity | 28 | $12,685 | $453 |
| Lyrica | 22 | $12,273 | $558 |
| Mesalamine | 11 | $7,816 | $711 |
| Gabapentin | 52 | $1,120 | $22 |
| Baclofen | 19 | $493 | $26 |
| Omeprazole | 14 | $436 | $31 |
| Cyproheptadine | 13 | $282 | $22 |
| Esomeprazole Magnesium | 13 | $231 | $18 |
| Mirtazapine | 19 | $185 | $10 |
| Dicyclomine | 12 | $159 | $13 |
| Ranitidine | 11 | $134 | $12 |
| Pantoprazole | 19 | $75 | $4 |
2018: 16 drugs
| Xifaxan | 18 | $31,252 | $1,736 |
| Linzess | 33 | $15,288 | $463 |
| Lyrica | 19 | $9,868 | $519 |
| Trulance | 19 | $7,554 | $398 |
| Amitiza | 13 | $7,063 | $543 |
| Carafate | 15 | $3,382 | $225 |
| Metoprolol | 14 | $737 | $53 |
| Gabapentin | 45 | $534 | $12 |
| Baclofen | 21 | $314 | $15 |
| Levothyroxine | 15 | $257 | $17 |
| Atorvastatin | 17 | $206 | $12 |
| Amlodipine Besylate | 14 | $179 | $13 |
| Lisinopril | 19 | $140 | $7 |
| Trazodone | 13 | $127 | $10 |
| Simvastatin | 18 | $106 | $6 |
| Pantoprazole | 15 | $76 | $5 |
2017: 28 drugs
| Metoprolol | 50 | $1,861 | $37 |
| Hydrocodone-Acetaminophen | 66 | $1,277 | $19 |
| Levothyroxine | 56 | $981 | $18 |
| Oxycodone-Acetaminophen | 21 | $910 | $43 |
| Atorvastatin | 51 | $771 | $15 |
| Ventolin Hfa | 14 | $750 | $54 |
| Diltiazem 24hr Er | 15 | $639 | $43 |
| Lisinopril | 94 | $534 | $6 |
| Fluticasone Propionate | 35 | $493 | $14 |
| Gabapentin | 41 | $489 | $12 |
| Divalproex | 11 | $337 | $31 |
| Losartan | 48 | $299 | $6 |
| Simvastatin | 34 | $281 | $8 |
| Cefuroxime | 11 | $273 | $25 |
| Trazodone | 29 | $247 | $9 |
| Diclofenac | 17 | $240 | $14 |
| Atenolol | 41 | $226 | $6 |
| Amlodipine Besylate | 46 | $225 | $5 |
| Montelukast | 22 | $217 | $10 |
| Metformin | 39 | $213 | $5 |
| Escitalopram | 31 | $174 | $6 |
| Paroxetine | 12 | $146 | $12 |
| Omeprazole | 19 | $142 | $7 |
| Hydrochlorothiazide | 25 | $139 | $6 |
| Sertraline | 15 | $122 | $8 |
| Lorazepam | 27 | $75 | $3 |
| Ranitidine | 14 | $71 | $5 |
| Allopurinol | 12 | $67 | $6 |
2016: 38 drugs
| Advair Diskus | 12 | $6,035 | $503 |
| Valsartan | 24 | $2,268 | $95 |
| Metoprolol | 34 | $1,512 | $44 |
| Levothyroxine | 61 | $1,219 | $20 |
| Ventolin Hfa | 18 | $955 | $53 |
| Hydrocodone-Acetaminophen | 34 | $827 | $24 |
| Proair Hfa | 11 | $805 | $73 |
| Lisinopril | 127 | $718 | $6 |
| Pravastatin | 38 | $600 | $16 |
| Fluticasone Propionate | 45 | $537 | $12 |
| Finasteride | 20 | $510 | $26 |
| Fluoxetine | 20 | $457 | $23 |
| Omeprazole | 53 | $425 | $8 |
| Gabapentin | 33 | $402 | $12 |
| Metformin | 81 | $398 | $5 |
| Simvastatin | 36 | $381 | $11 |
| Potassium Chloride | 15 | $348 | $23 |
| Losartan | 54 | $329 | $6 |
| Amlodipine Besylate | 64 | $311 | $5 |
| Atorvastatin | 23 | $311 | $14 |
| Dasetta | 13 | $288 | $22 |
| Lovastatin | 35 | $284 | $8 |
| Atenolol | 59 | $283 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $264 | $24 |
| Tamsulosin | 16 | $261 | $16 |
| Cartia Xt | 13 | $201 | $15 |
| Benazepril | 21 | $193 | $9 |
| Trazodone | 27 | $188 | $7 |
| Glimepiride | 27 | $160 | $6 |
| Donepezil | 16 | $154 | $10 |
| Hydrochlorothiazide | 32 | $122 | $4 |
| Allopurinol | 14 | $109 | $8 |
| Furosemide | 15 | $93 | $6 |
| Ranitidine | 22 | $93 | $4 |
| Naproxen | 13 | $88 | $7 |
| Metoprolol | 19 | $77 | $4 |
| Carvedilol | 15 | $69 | $5 |
| Sertraline | 12 | $59 | $5 |
2015: 11 drugs
| Triamcinolone Acetonide | 16 | $892 | $56 |
| Lisinopril | 53 | $343 | $6 |
| Levothyroxine | 20 | $330 | $16 |
| Hydrocodone-Acetaminophen | 13 | $292 | $22 |
| Fluticasone Propionate | 23 | $258 | $11 |
| Losartan | 38 | $232 | $6 |
| Metformin | 32 | $164 | $5 |
| Gabapentin | 13 | $150 | $12 |
| Omeprazole | 20 | $146 | $7 |
| Simvastatin | 19 | $108 | $6 |
| Amlodipine Besylate | 28 | $86 | $3 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306253315
- Licence
- CA 95000747
- Group
- Stanford Health Care · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 900 Blake Wilbur Dr, Ground Fl Mc 5355, Stanford, CA, 94305
- NPI first listed
- 2014-07-22
- NPI last updated
- 2018-09-25
This is when the NPI record was last certified, not a medical board exam.